Avicenna Biosciences was founded to solve the intractable challenges that previously stopped drug candidates in their tracks. We have created an ML-driven medicinal chemistry platform that makes Lead Optimization faster, cheaper, and more successful – transforming sub-optimal development candidates into life-saving drugs. The platform has seen rapid success in discovering the first orally available, CNS-penetrant ROCK inhibitors for the treatment of neurodegenerative diseases, with IND-enabling studies initiated just one year since the program kicked off.
Company Details
- Employees
- 12
- Founded
- 2020
- Address
- 101 W Chapel Hill St, Durham,north Carolina 27701,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.avicenna-bio.com
- Keywords
- biotechnology, machine learning, drug discovery, drug development, artificial intelligence, small molecules, medicinal chemistry, lead optimization, FEP.
- HQ
- Durham, North Carolina
Avicenna Biosciences, Inc. Questions
Avicenna Biosciences, Inc.'s website is http://www.avicenna-bio.com
Avicenna Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/avicenna-biosciences
Avicenna Biosciences, Inc. has
12 employees.
View email and phone details for 12
employees at Avicenna Biosciences, Inc..
Avicenna Biosciences, Inc.'s industry is
Biotechnology Research
Avicenna Biosciences, Inc.'s top competitors are
Latus Bio,
Recursion,
Arrowhead Pharmaceuticals,
Nilo Therapeutics,
Incubate Coalition,
Radionetics Oncology,
Auron Therapeutics, Inc.,
Dcvc Bio,
Frontier Medicines,
Avicenna™.
Avicenna Biosciences, Inc.'s categories are Biotechnology Research
Avicenna Biosciences, Inc.'s founding year is 2020
